Schmidt R, Schmidt H, Kapeller P, Enzinger C, Ropele S, Saurugg R et al. The natural course of MRI white matter hyperintensities. J Neurol Sci 2002; 203-204: 253–257.
Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010; 341: c3666.
Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113: 898–918.
Dehlendorff C, Andersen KK, Olsen TS. Body mass index and death by stroke: no obesity paradox. JAMA Neurol 2014; 71: 978–984.
Doehner W, Schenkel J, Anker SD, Springer J, Audebert HJ. Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. Eur Heart J 2013; 34: 268–277.
Kim BJ, Lee SH, Jung KH, Yu KH, Lee BC, Roh JK et al. Dynamics of obesity paradox after stroke, related to time from onset, age, and causes of death. Neurology 2012; 79: 856–863.
Kim CK, Ryu WS, Kim BJ, Lee SH. Paradoxical effect of obesity on hemorrhagic transformation after acute ischemic stroke. BMC Neurol 2013; 13: 123.
Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28: 1039–1049.
Lim S, Meigs JB. Links between ectopic fat and vascular disease in humans. Arterioscler Thromb Vasc Biol 2014; 34: 1820–1826.
Anan F, Masaki T, Eto T, Iwao T, Shimomura T, Umeno Y et al. Visceral fat accumulation is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients. Eur J Clin Invest 2009; 39: 368–374.
Widya RL, Kroft LJ, Altmann-Schneider I, van den Berg-Huysmans AA, van der Bijl N, de Roos A et al. Visceral adipose tissue is associated with microstructural brain tissue damage. Obesity (Silver Spring) 2015; 23: 1092–1096.
Yamashiro K, Tanaka R, Tanaka Y, Miyamoto N, Shimada Y, Ueno Y et al. Visceral fat accumulation is associated with cerebral small vessel disease. Eur J Neurol 2014; 21: 667–673.
Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837–1847.
Kwak MS, Kim D, Chung GE, Kim W, Kim YJ, Yoon JH. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance. Liver Int 2015; 35: 944–952.
Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepfer WW et al. pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly. AJR Am J Roentgenol 1988; 151: 559–566.
Chung SJ, Kim D, Park MJ, Kim YS, Kim JS, Jung HC et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008; 57: 1360–1365.
Kim D, Choi SY, Park EH, Lee W, Kang JH, Kim W et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 2012; 56: 605–613.
Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci 2013; 1281: 64–91.
Huxley R, James WP, Barzi F, Patel JV, Lear SA, Suriyawongpaisal P et al. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev 2008; 9: 53–61.
Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev 2002; 3: 141–146.
Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998; 22: 1164–1171.
Choi HS, Cho YM, Kang JH, Shin CS, Park KS, Lee HK. Cerebral white matter hyperintensity is mainly associated with hypertension among the components of metabolic syndrome in Koreans. Clin Endocrinol (Oxf) 2009; 71: 184–188.
Isaac V, Sim S, Zheng H, Zagorodnov V, Tai ES, Chee M. Adverse associations between visceral adiposity, brain structure, and cognitive performance in healthy elderly. Front Aging Neurosci 2011; 3: 12.
Karcher HS, Holzwarth R, Mueller HP, Ludolph AC, Huber R, Kassubek J et al. Body fat distribution as a risk factor for cerebrovascular disease: an MRI-based body fat quantification study. Cerebrovasc Dis 2013; 35: 341–348.
Mathieu P, Lemieux I, Despres JP. Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther 2010; 87: 407–416.
Esenwa CC, Elkind MS. Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Nat Rev Neurol 2016; 12: 594–604.
Mitaki S, Nagai A, Oguro H, Yamaguchi S. C-reactive protein levels are associated with cerebral small vessel-related lesions. Acta Neurol Scand 2016; 133: 68–74.
Shoamanesh A, Preis SR, Beiser AS, Vasan RS, Benjamin EJ, Kase CS et al. Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study. Neurology 2015; 84: 825–832.
Wada M, Nagasawa H, Kurita K, Koyama S, Arawaka S, Kawanami T et al. Cerebral small vessel disease and C-reactive protein: results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 2008; 264: 43–49.
Fornage M, Chiang YA, O'Meara ES, Psaty BM, Reiner AP, Siscovick DS et al. Biomarkers of inflammation and MRI-defined small vessel disease of the brain: the Cardiovascular Health Study. Stroke 2008; 39: 1952–1959.
Schmidt R, Schmidt H, Pichler M, Enzinger C, Petrovic K, Niederkorn K et al. C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention Study. Stroke 2006; 37: 2910–2916.
van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 2005; 112: 900–905.
Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460–468.
Zamboni M, Turcato E, Armellini F, Kahn HS, Zivelonghi A, Santana H et al. Sagittal abdominal diameter as a practical predictor of visceral fat. Int J Obes Relat Metab Disord 1998; 22: 655–660.
Yim JY, Kim D, Lim SH, Park MJ, Choi SH, Lee CH et al. Sagittal abdominal diameter is a strong anthropometric measure of visceral adipose tissue in the Asian general population. Diabetes Care 2010; 33: 2665–2670.
van Norden AG, de Laat KF, van Dijk EJ, van Uden IW, van Oudheusden LJ, Gons RA et al. Diffusion tensor imaging and cognition in cerebral small vessel disease: the RUN DMC study. Biochim Biophys Acta 2012; 1822: 401–407.
Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol 2015; 11: 157–165.